BME:PRS Statistics

Total Valuation

BME:PRS has a market cap or net worth of EUR 494.29 million. The enterprise value is 1.24 billion.

Market Cap	494.29M
Enterprise Value	1.24B

Important Dates

The next estimated earnings date is Friday, April 25, 2025.

Earnings Date	Apr 25, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:PRS has 1.34 billion shares outstanding. The number of shares has increased by 34.94% in one year.

Current Share Class	n/a
Shares Outstanding	1.34B
Shares Change (YoY)	+34.94%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	8.91%
Owned by Institutions (%)	7.15%
Float	375.61M

Valuation Ratios

PE Ratio	n/a
Forward PE	24.60
PS Ratio	0.54
PB Ratio	-1.34
P/TBV Ratio	n/a
P/FCF Ratio	4.27
P/OCF Ratio	3.88
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.76, with an EV/FCF ratio of 10.72.

EV / Earnings	-107.11
EV / Sales	1.36
EV / EBITDA	6.76
EV / EBIT	10.68
EV / FCF	10.72

Financial Position

The company has a current ratio of 1.34

Current Ratio	1.34
Quick Ratio	1.20
Debt / Equity	n/a
Debt / EBITDA	4.93
Debt / FCF	7.68
Interest Coverage	1.37

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	7.61%
Return on Invested Capital (ROIC)	13.06%
Return on Capital Employed (ROCE)	22.04%
Revenue Per Employee	125,354
Profits Per Employee	-1,586
Employee Count	7,295
Asset Turnover	0.99
Inventory Turnover	7.69

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +8.53% in the last 52 weeks. The beta is 0.56, so BME:PRS's price volatility has been lower than the market average.

Beta (5Y)	0.56
52-Week Price Change	+8.53%
50-Day Moving Average	0.38
200-Day Moving Average	0.35
Relative Strength Index (RSI)	45.18
Average Volume (20 Days)	1,045,553

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:PRS had revenue of EUR 914.46 million and -11.57 million in losses. Loss per share was -0.01.

Revenue	914.46M
Gross Profit	479.84M
Operating Income	112.85M
Pretax Income	19.26M
Net Income	-11.57M
EBITDA	154.05M
EBIT	112.85M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 156.88 million in cash and 888.52 million in debt, giving a net cash position of -731.64 million or -0.55 per share.

Cash & Cash Equivalents	156.88M
Total Debt	888.52M
Net Cash	-731.64M
Net Cash Per Share	-0.55
Equity (Book Value)	-368.48M
Book Value Per Share	-0.35
Working Capital	123.70M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 127.41 million and capital expenditures -11.76 million, giving a free cash flow of 115.64 million.

Operating Cash Flow	127.41M
Capital Expenditures	-11.76M
Free Cash Flow	115.64M
FCF Per Share	0.09

Full Cash Flow Statement

Margins

Gross margin is 52.47%, with operating and profit margins of 12.34% and -1.27%.

Gross Margin	52.47%
Operating Margin	12.34%
Pretax Margin	2.11%
Profit Margin	-1.27%
EBITDA Margin	16.85%
EBIT Margin	12.34%
FCF Margin	12.65%

Dividends & Yields

BME:PRS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-34.94%
Shareholder Yield	-34.94%
Earnings Yield	-2.34%
FCF Yield	23.40%

Stock Splits

The last stock split was on May 22, 2015. It was a reverse split with a ratio of 0.0333333333.

Last Split Date	May 22, 2015
Split Type	Reverse
Split Ratio	0.0333333333

Scores

BME:PRS has an Altman Z-Score of 0.89. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.89
Piotroski F-Score	n/a